Literature DB >> 10708132

Large de novo renal cell carcinoma in a 10-year-old transplanted kidney: successful organ-preserving therapy.

M Siebels1, J Theodorakis, B Liedl, P Schneede, A Hofstetter.   

Abstract

BACKGROUND: A recent review of the Cincinnati Transplant Tumor Registry recorded 24 de novo renal cell carcinomas developing in renal allografts. However, late development of these tumors after transplantation is very rare. Only four reports exist regarding conservative surgery on kidney transplant tumors.
METHODS: This is a report on a case of a large 6-cm de novo renal cell carcinoma in a 10-year-old transplanted kidney. Optimal therapy by transplant nephrectomy or tumor enucleation was discussed.
RESULTS: Partial resections or enucleations of renal cell carcinoma are still less than ideal in carcinomas larger than 3 cm considering the higher risk of local recurrence. But the recipient in this case had done so well and had had such a high quality of life after transplantation that partial nephrectomy as therapy of choice was selected. Now the patient is 2 years tumor free.
CONCLUSION: The case report demonstrates that in certain select cases of large tumors, organ-preserving surgery could be an alternative approach in combining complete tumor removal with preservation of graft function.

Entities:  

Mesh:

Year:  2000        PMID: 10708132     DOI: 10.1097/00007890-200002270-00037

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

1.  Papillary renal cell carcinoma in allograft kidney.

Authors:  Catherine Roy; Sofiane El Ghali; Xavier Buy; Véronique Lindner; Afshin Gangi
Journal:  Eur Radiol       Date:  2004-09-17       Impact factor: 5.315

Review 2.  Immunotherapy in metastatic renal cell carcinoma.

Authors:  Karl Rohrmann; Michael Staehler; Nikolas Haseke; Alexander Bachmann; Christian G Stief; Michael Siebels
Journal:  World J Urol       Date:  2005-04-02       Impact factor: 4.226

3.  Renal transplantation with kidneys affected by tumours.

Authors:  Muhammad Arslan Khurram; Aliu Oladipupo Sanni; David Rix; David Talbot
Journal:  Int J Nephrol       Date:  2011-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.